An immunogenicity, safety and post-marketing surveillance of a novel adsorbed human diploid cell rabies vaccine (Rabivax) in Indian subjects.

Sudarshan, M K; Bhardwaj, S; Mahendra, B J; Sharma, H; Sanjay, T V; Ashwathnarayana, D H; Bilagumba, Gangaboraiah

Sudarshan, M K; Bhardwaj, S; Mahendra, B J; Sharma, H; Sanjay, T V; Ashwathnarayana, D H; Bilagumba, Gangaboraiah.

Affiliation

Sudarshan MK; Department of Community Medicine and Rabies, Epidemiology Unit, Kempegowda Institute of Medical Sciences, Bangalore, India. mksudarshan@vsnl.com

Hum Vaccin ; 4(4): 275-9, 2008.

Article in En | MEDLINE | ID: mdl-18682695

Subject(s)

Product Surveillance, Postmarketing; Rabies Vaccines/adverse effects; Rabies Vaccines/immunology; Rabies/prevention & control; Adolescent; Adult; Animals; Antibodies, Viral/blood; Bites and Stings; Child; Child, Preschool; Clinical Trials as Topic; Diploidy; Dogs; Edema/immunology; Female; Fever/immunology; Headache/immunology; Humans; India; Injections, Intramuscular; Male; Middle Aged; Neutralization Tests; Pain/immunology; Rabies/immunology; Rabies Vaccines/administration & dosage; Rabies virus/immunology; Time Factors; Vaccination/adverse effects

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Product Surveillance, Postmarketing / Rabies / Rabies Vaccines Type of study: Screening_studies Limits: Adolescent / Adult / Animals / Child / Child, preschool / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Year: 2008 Type: Article

Search on Google

XML

PubMed Links